Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Pain Links Fibromyalgia & RA

Arthritis & Rheumatology  |  Issue: July 2018  |  June 26, 2018

Objective: Many patients with rheumatoid arthritis (RA) report pain despite excellent control of inflammation with immunotherapies.

This disconnect between improvements in inflammation and improvements in pain suggests a likely contribution of pain mechanisms in addition to and distinct from peripheral inflammation. Central sensitization—a consequence of dysfunctional central nervous system (CNS) pain processing, which defines the primary chronic pain syndrome of fibromyalgia (FM)—may represent one such mechanism. This possibility is supported by clinical epidemiologic research that has found evidence of coexisting FM in 13–25% of RA patients (compared with a prevalence of 1–5% in the general population). An additional 7–15% of RA patients have hallmark features of FM (which include somatic symptoms, such as fatigue, as well as chronic pain) without meeting the ACR 1990 classification criteria. Wolfe and colleagues derived a continuous scale from the ACR FM survey criteria and found that it predicted pain and disability in RA even among patients who did not fully satisfy the FM criteria. The term fibromyalgianess (FMness) was subsequently introduced to reflect this wide phenotypic range.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The authors undertook this study to test the hypothesis that RA patients with the highest 2011 ACR FM survey criteria scores—a continuous measure of the degree of FMness—would demonstrate functional connectivity abnormalities similar to those in FM.

Methods: RA patients underwent an 11-minute functional connectivity magnetic resonance imaging (MRI) brain scan and a clinical evaluation which included a measure of FMness. Brain networks were isolated from functional connectivity MRI data. Individual patient network-to-whole brain connectivity analyses were then conducted, followed by group-level regression, which correlated the connectivity of each network with FMness.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Results: A total of 54 patients participated (mean age 54.9 years, 75.9% women, mean FMness score 13.2 [range 1–29]). From the whole brain analyses, a single significant positive correlation between DMN connectivity to the left mid/posterior insula and FMness (r=0.58, FWE-corrected P=0.001) was demonstrated.

Conclusion: RA patients who have increased levels of FMness appear to share neurobiologic features consistently observed in FM patients. This study is the first to provide neuroimaging evidence that RA is a mixed pain state, with many patients’ symptoms being related to the central nervous system rather than to classic inflammatory mechanisms.

Excerpted and adapted from:

Basu N, Kaplan CM, Ichesco E, et al. Neurobiologic features of fibromyalgia are also present among rheumatoid arthritis patients. Arthritis Rheumatol. 2018 Jul;70(7):1000–1007.

Share: 

Filed under:ConditionsPain SyndromesResearch RheumRheumatoid Arthritis Tagged with:Arthritis & RheumatologyFibromyalgiaPainResearchRheumatoid Arthritis (RA)

Related Articles

    fMRI Provides Visual Evidence of Pain

    January 1, 2015

    Functional MRI scans that show how pain changes the brain could help rheumatologists develop better approaches to pain relief

    Fibromyalgia Pain Associated with Changes in Brain Connectivity

    July 25, 2014

    Research suggests weakened sensory cortex connectivity extending beyond the traditional somatosensory domain may contribute to pain associated with fibromyalgia

    Meet the Challenge of Primary CNS Vasculitis

    September 1, 2011

    Diagnosis and treatment of this rare and poorly understood condition

    Chronic Pain Research Probes Neurologic Pain Pathways, Biomarkers

    February 18, 2018

    With the aid of increasingly sophisticated neuroimaging technology, research into how the brain activates and changes in patients with chronic pain is delivering fascinating information that will hopefully pave the way to tailored, individual treatment of chronic pain. Over the past several years, data from neuroimaging studies have provided a new understanding of what occurs…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences